19 May 2013
Keywords: merck, co, study, iomai, vacc, booster, patch
Article | 14 April 2008
Iomai Corp has signed an agreement with fellow USA-based Merck & Co to conduct proof-of-principle preclinical studies evaluating the use of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 April 2008
17 May 2013
© 2013 thepharmaletter.com